azacitidine has been researched along with Polyradiculoneuropathy, Chronic Inflammatory Demyelinating in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attarian, S; Delmont, E; Escoda, T; Farnault, L; Gallard, J; Marceau-Renaut, A | 1 |
1 other study(ies) available for azacitidine and Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
| Article | Year |
|---|---|
Azacitidine, a therapeutic option in Lewis and Sumner syndrome associated with VEXAS syndrome.
Topics: Azacitidine; Humans; Neural Conduction; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Syndrome | 2022 |